查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1770863

尿液分析市場 - 全球產業規模、佔有率、趨勢、競爭、機會和預測，按產品、按測試類型、按應用、按最終用戶、按地區和競爭進行細分，2020-2030 年

Urinalysis Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product, By Test Type, By Application, By End user, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球尿液分析市場規模為43.9億美元，預計2030年將達到68.4億美元，複合年成長率為7.67%。這一成長主要得益於糖尿病和腎臟疾病等慢性疾病的日益流行。尿液分析是一種診斷方法，透過檢查尿液的物理、化學和微觀特性來檢測和監測一系列健康狀況，包括泌尿道感染、腎臟疾病和糖尿病。作為一種非侵入性且資訊豐富的檢測方法，尿液分析在早期診斷和疾病管理中的重要性日益凸顯。此外，大眾對泌尿和腎臟健康意識的不斷提高，加上政府支持和醫療保健投入的增加，正在提高該檢測的可及性，並刺激已開發市場和發展中市場的需求。

市場概覽
預測期 2026-2030
2024年市場規模 43.9億美元
2030年市場規模 68.4億美元
2025-2030 年複合年成長率 7.67%
成長最快的領域 儀器
最大的市場 北美洲

關鍵市場促進因素

慢性病盛行率上升

主要市場挑戰

法規遵從和品質控制

主要市場趨勢

轉向即時檢驗

目錄

第 1 章：按產品概述

  • 市場定義
  • 市場範圍
    • 覆蓋的市場。
    • 考慮學習的年限
    • 主要市場區隔

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：尿液分析市場展望。

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品（消耗品和儀器）
    • 按測試類型（妊娠和生育測試、生化尿液分析和沈渣尿液分析）
    • 按應用（疾病篩檢及妊娠及生育）
    • 按最終使用者（診斷實驗室、醫院和診所、家庭護理機構以及研究實驗室和研究所）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：亞太尿液分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國 。
    • 印度 。
    • 韓國
    • 日本
    • 澳洲

第7章：歐洲尿液分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：北美尿液分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章：南美尿液分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲尿液分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 併購
  • 按產品開發

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 14 章：尿液分析市場：SWOT 分析

第 15 章：競爭格局

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Cardinal Health Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Quidel Corporation
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories Inc.
  • EKF Diagnostics Holdings plc

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15094

The Global Urinalysis Market was valued at USD 4.39 billion in 2024 and is projected to reach USD 6.84 billion by 2030, growing at a CAGR of 7.67%. This growth is largely driven by the increasing prevalence of chronic diseases such as diabetes and kidney disorders. Urinalysis is a diagnostic method that examines the physical, chemical, and microscopic properties of urine to detect and monitor a range of health conditions, including urinary tract infections, kidney disease, and diabetes. As a non-invasive and informative testing approach, urinalysis is gaining prominence in early diagnosis and disease management. Additionally, rising public awareness about urinary and kidney health, combined with increased government support and healthcare investment, is enhancing accessibility and fueling demand across both developed and developing markets.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.39 Billion
Market Size 2030USD 6.84 Billion
CAGR 2025-20307.67%
Fastest Growing SegmentInstruments
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global rise in chronic conditions-particularly diabetes and chronic kidney disease (CKD)-is a major factor accelerating the growth of the urinalysis market. Urinalysis is a non-invasive, affordable diagnostic tool that plays a critical role in early detection, ongoing monitoring, and treatment planning for these diseases.

According to the World Health Organization (WHO), the global population aged 60 and above is expected to reach 2.1 billion by 2050, significantly increasing the incidence of age-related illnesses such as diabetes and CKD. The International Diabetes Federation noted that 537 million adults were living with diabetes in 2021, with projections indicating this figure will rise to 643 million by 2030. Urinalysis enables detection of biomarkers like glucose, ketones, and protein in urine, making it essential for effective management and timely intervention.

Key Market Challenges

Regulatory Compliance and Quality Control

The urinalysis market faces significant regulatory and quality assurance challenges. Manufacturers must meet stringent requirements imposed by bodies such as the FDA and EMA, which involve comprehensive product testing, documentation, and adherence to Good Manufacturing Practices (GMP). These compliance processes can be time-consuming and financially demanding.

Ensuring consistency in product performance across production batches is crucial, as any variation can compromise diagnostic accuracy. This necessitates rigorous quality control mechanisms and ongoing surveillance. For example, under the FDA's Medical Device Reporting (MDR) regulation, manufacturers are required to report device-related adverse events, ensuring constant monitoring and safety validation. These high standards increase the operational burden, potentially limiting market entry for smaller players and slowing innovation due to the associated costs and complexities.

Key Market Trends

Shift Towards Point-of-Care Testing

A major trend in the urinalysis market is the transition toward point-of-care testing (POCT), driven by the need for rapid diagnostics and decentralized healthcare services. POCT enables immediate testing and results interpretation at the site of care, which enhances clinical responsiveness and patient outcomes.

Urinalysis has emerged as a key area within POCT, thanks to the development of portable, easy-to-use devices that can be deployed in clinics, emergency rooms, and even at home. These devices offer fast analysis of urine parameters like glucose, protein, and leukocytes, facilitating prompt diagnosis and treatment.

Government support has further strengthened this trend. For instance, the Centers for Medicare & Medicaid Services (CMS) in the U.S. have introduced reimbursement policies that encourage POCT use in primary care. During health crises such as the COVID-19 pandemic, regulatory bodies also accelerated the approval of POCT devices to expand diagnostic capacity, underscoring the growing role of POCT in the future of healthcare.

Key Market Players

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Cardinal Health Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Quidel Corporation
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories Inc.
  • EKF Diagnostics Holdings plc

Report Scope:

In this report, the Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urinalysis Market, By Product:

  • Consumables
  • Instruments

Urinalysis Market, By Test Type:

  • Pregnancy & Fertility Tests
  • Biochemical Urinalysis
  • Sediment Urinalysis

Urinalysis Market, By Application:

  • Disease Screening
  • Pregnancy & Fertility

Urinalysis Market, By End User:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories & Institutes

Urinalysis Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Urinalysis Market.

Available Customizations:

Global Urinalysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. By Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Urinalysis Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables & Instruments)
    • 5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
    • 5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
    • 5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. Asia-Pacific Urinalysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Test Type
    • 6.2.3. By Application
    • 6.2.4. By End user
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Urinalysis Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End user
    • 6.3.2. India Urinalysis Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End user
    • 6.3.3. South Korea Urinalysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End user
    • 6.3.4. Japan Urinalysis Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Test Type
        • 6.3.4.2.3. By Application
        • 6.3.4.2.4. By End user
    • 6.3.5. Australia Urinalysis Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Test Type
        • 6.3.5.2.3. By Application
        • 6.3.5.2.4. By End user

7. Europe Urinalysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Test Type
    • 7.2.3. By Application
    • 7.2.4. By End user
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Urinalysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End user
    • 7.3.2. Germany Urinalysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End user
    • 7.3.3. United Kingdom Urinalysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End user
    • 7.3.4. Italy Urinalysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End user
    • 7.3.5. Spain Urinalysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End user

8. North America Urinalysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Test Type
    • 8.2.3. By Application
    • 8.2.4. By End user
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Urinalysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End user
    • 8.3.2. Mexico Urinalysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End user
    • 8.3.3. Canada Urinalysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End user

9. South America Urinalysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Test Type
    • 9.2.3. By Application
    • 9.2.4. By End user
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Urinalysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End user
    • 9.3.2. Argentina Urinalysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End user
    • 9.3.3. Colombia Urinalysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End user

10. Middle East and Africa Urinalysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Test Type
    • 10.2.3. By Application
    • 10.2.4. By End user
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Urinalysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End user
    • 10.3.2. Saudi Arabia Urinalysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End user
    • 10.3.3. UAE Urinalysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. By Product Developments

13. Porters Five Forces Analysis

  • 1.1. Competition in the Industry
  • 1.2. Potential of New Entrants
  • 1.3. Power of Suppliers
  • 1.4. Power of Customers
  • 1.5. Threat of Substitute Products/Services

14. Urinalysis Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. F. Hoffmann-La Roche Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. By Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Siemens Healthineers AG
  • 15.3. Abbott Laboratories
  • 15.4. Cardinal Health Inc.
  • 15.5. Danaher Corporation
  • 15.6. Sysmex Corporation
  • 15.7. Quidel Corporation
  • 15.8. Becton, Dickinson & Company
  • 15.9. Bio-Rad Laboratories Inc.
  • 15.10. EKF Diagnostics Holdings plc

16. Strategic Recommendations

17. About Us & Disclaimer